Ren, B., Pueyo, L., Zhu, G
Microdose GLP-1s shipped to your door Easy at-home biomarkers testing Microhabits for results that stick See if youre eligible Health you can see, wellbeing you can feel See the change for yourself with easy, at-home biomarker testing every 4 months
Semaglutide is a GLP-1 receptor agonist that, for many patients, provides sufficient appetite control and weight loss support without needing the dual-agonist approach that tirzepatide offers
If you have documented obesity that is a health risk, then insurers are more receptive. Levin-Scherz notes the consulting firm is seeing more drug manufacturers sell GLP-1s directly to consumers, bypassing employer and insurer decisions
Reducing dose or frequency typically resolves this
Published 2024 Feb 19